1 of 41

Performance Results �P4, 2021

TB/HIV-RSSH 2021-2023 Grant

18 March 2022

2 of 41

OUTLINE

  1. Programmatic Indicators
  2. Finance Indicators
  3. Compliance Indicators
  4. Management Indicators
  5. PSM & Stock level
  6. Last rating

​

​

​

​

3 of 41

1 Programmatic Indicators�

3

4 of 41

5 of 41

​

​

  • Poor submission rate negatively affected case notifications and other TB related indicators

​

Case Notifications

6 of 41

​

​

​

  • 90% threshold achieved

​

  • 4180/5613 cases successfully treated
  • Coverage is 74%

Success Rate

7 of 41

​

​

​

​

  • Results dropped from previous period
  • Within 70% threshold
  • 3,313/5,915 TB cases screened for HIV
  • Coverage is 56%

HIV Screening

8 of 41

​

​

  • Performance still struggling
  • Slight improvement from previous report

​

RR-TB and/or MDR TB Notified

9 of 41

​

​

​

  • Performance still struggling
  • Slight improvement from previous report

​

​

​

​

RR-TB and/or MDR TB began 2ndline Tx

10 of 41

​

​

​

  • Exceeded 90% threshold
  • Improved from previous period
  • 90% coverage rate

HIV+ patients on ART during TB Tx

11 of 41

​

​

​

  • Exceeded 90% threshold

​

PLHIV currently on ART

12 of 41

​

​

​

  • Data from 43 ART sites (HPDB)
  • Worrying trend of slow progress
  • PR will continue to support implementation of IPT rollout and monitor performance.
  • NDoH continues working with PHAs to mentor them, and also ensure all ART sites have adequate supplies of INH

​

PLHIV started on TB Preventive Therapy

13 of 41

​

​

​

  • Data from trackers for HPDB (HIV) and Quarterly BMU reports (TB)
  • 77 TB BMU reports plus 105 HIV (HPDB) reports
  • Placement of PSOs at provincial level is expected to strengthen timely submission of reports

​

​

Timely Submissions (M&E-2b)

14 of 41

HIV KP outreach

15 of 41

  • Data from KP database maintained by SRs in 7 HIV provinces
  • Results below 70% threshold
  • Outreach scaled down in December

​

​

MSM Reached

16 of 41

  • Data from KP database maintained by SRs in 7 HIV provinces
  • Results dropped
  • Outreach scaled down in December

MSM Tested

17 of 41

  • Data from KP database maintained by SRs in 7 HIV provinces
  • Results dropped due to exclusion of MSW.
  • MSW data is being validated for quality issues
  • Outreach scaled down in December

SW Reached

18 of 41

  • Data from KP database maintained by SRs in 7 HIV provinces
  • Results dropped due to exclusion of MSW.
  • MSW data is being validated for quality issues
  • Outreach scaled down in December

​

SW Tested

19 of 41

2 Finance Indicators�Budget & expenses include CRM 19

19

20 of 41

  • Approved in Oct/Nov 2021
  • IL received in November 2021

​

  • Total Amount: $22,944,851
    • Fast Track: USD 5,784,985
    • Full Funding Request: USD 17,159,866

​

  • Budget & expenditures presented in preceding slides include CRM 19

​

CRM 19 Funds

21 of 41

  • Procurement and distribution of Covid19 related Health Products: AG/RDTs, PPE, GeneXpert machines and cartridges
  • Community strengthening, GBV interventions and supporting risk communication
  • Health systems strengthening: Significant investment in:
    • field epidemiology training program and outbreak surveillance systems,
    • GeneXpert connectivity,
    • diagnostics optimization study,
    • enhancement of VL monitoring and
    • supporting human resources for health.

​

Main Focus of CRM 19 Funds

22 of 41

Grant total: Cumulative by quarter

Cumulative at P4:

  • Budget: $24,809,409
  • Disbursed: $14,043,742
  • Expensed: $13,216,830

​

​

  • The cumulative for P4 also includes Susu Mama Inc.

23 of 41

  • Igat Hope is operating on zero-cash basis – finance managed by PR

​

​

(PR’s rating not shown – details on next slide)

​

Implementers (SR)

24 of 41

World Vision (PR)

  • One (1) disbursement received in Q4

cumulative by Quarter

25 of 41

  • Disbursement received in P4
  • Absorption rate dropped in P4

ADRA

26 of 41

​

  • Absorption rate dropped in P4

APNG

27 of 41

  • Absorption rate at 103%

Burnet Institute (BI)

28 of 41

  • Absorption rate improved

Hope World Wide (HWW)

29 of 41

  • Zero-cash basis
  • Finance managed by PR

Igat Hope (IH)

CUMULATIVE at P4

30 of 41

  • Disbursement was for planned activities of previous quarters to be implemented in Q4.
  • Disbursement delayed due to ongoing discussions between IP and PR

Susu Mama Inc.

​

Period 1�Q1-21 

 Period 2�Q2-21 

 Period 3�Q3-21 

 Period 4�Q4-21 

Budget

14,361

10,050

80,737

10,050

Disbursement

0

0

0

15,840

Expensed

0

0

0

0

31 of 41

3 Compliance Indicators�

31

32 of 41

​

​

  • Recommendations from Supportive visits will be tracked & reported in the next period

Compliance

33 of 41

4 Management Indicators�

33

34 of 41

  • 59 Vacant positions
  • 136 Positions planned:
    • 70 under C19
    • 66 under NFM3

​

  • Recruitment is ongoing

​

MANAGEMENT

35 of 41

5 PSM & Stock level

35

36 of 41

  • PSM Cost Budget:

77,648

  • PSM exp. Plus Commitment:

531,556

(488,473 + 43083)

​

  • H/Products & Equip. Budget: 824,533
  • H/Products & equip. exp. Plus Commitment:

3,269,828

(2,134,980 + 1,134,848)

​

Total Grant to date: PSM

37 of 41

  • Sanpshot of Stock status at P4

​

  • Updated stock status at March 16th will be shared

Stock Level

38 of 41

6 Last rating�

38

39 of 41

Last rating: July – Dec 2020 PUDR

Recent PUDR rating not available

40 of 41

Last rating: July – Dec 2020

41 of 41

Thank you